Elizabeth Herries

2.2k total citations
15 papers, 777 citations indexed

About

Elizabeth Herries is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Elizabeth Herries has authored 15 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 9 papers in Psychiatry and Mental health and 4 papers in Molecular Biology. Recurrent topics in Elizabeth Herries's work include Alzheimer's disease research and treatments (10 papers), Dementia and Cognitive Impairment Research (9 papers) and Acute Kidney Injury Research (2 papers). Elizabeth Herries is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Dementia and Cognitive Impairment Research (9 papers) and Acute Kidney Injury Research (2 papers). Elizabeth Herries collaborates with scholars based in United States, Netherlands and United Kingdom. Elizabeth Herries's co-authors include Jack H. Ladenson, Anne M. Fagan, David M. Holtzman, John C. Morris, Courtney L. Sutphen, Charlotte E. Teunissen, Philip Scheltens, Wiesje M. van der Flier, Daniel L. Crimmins and Maartje I. Kester and has published in prestigious journals such as Neurology, Annals of Neurology and Clinical Chemistry.

In The Last Decade

Elizabeth Herries

14 papers receiving 770 citations

Peers

Elizabeth Herries

PHYSI

PMH

NEURO

Liyong Wu China

Ignacio Illán‐Gala Spain

Hanne Struyfs Belgium

Sarah Anderl‐Straub Germany

Batool Rizvi United States

Koji Kasanuki Japan

Ronald Druyeh United Kingdom

Misha M. Riley United States

Stefanie H. Freeman United States

Fabian Corlier France

Liyong Wu China

Elizabeth Herries

297 ×0.5

PHYSI

242 ×0.7

PMH

135 ×0.7

129 ×0.7

NEURO

91 ×0.7

NEURO

Citations per year, relative to Elizabeth Herries Elizabeth Herries (= 1×) peers Liyong Wu

Countries citing papers authored by Elizabeth Herries

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Herries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Herries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Herries more than expected).

Fields of papers citing papers by Elizabeth Herries

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Herries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Herries. The network helps show where Elizabeth Herries may publish in the future.

Co-authorship network of co-authors of Elizabeth Herries

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Herries. A scholar is included among the top collaborators of Elizabeth Herries based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Herries. Elizabeth Herries is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Herries, Elizabeth, Mark A. Zaydman, Christopher W Farnsworth, et al.. (2024). Clinical Utility of LC-MS/MS for Blood Myo-Inositol in Patients with Acute Kidney Injury and Chronic Kidney Disease. Clinical Chemistry. 70(9). 1172–1181. 3 indexed citations

Eldaief, Mark C., Alexandra Touroutoglou, Michael Brickhouse, et al.. (2024). Utility of CSF biomarkers in assessing neurodegeneration in Early‐Onset Alzheimer’s disease. Alzheimer s & Dementia. 20(S2). 1 indexed citations

Herries, Elizabeth, et al.. (2023). LC/MS-MS quantification of myo-inositol: a novel biomarker for kidney disease. American Journal of Clinical Pathology. 160(Supplement_1). S117–S118. 1 indexed citations

Tipton, Philip W., Yuka A. Martens, Matthew R. Brier, et al.. (2023). Diagnostic Utility of Cerebrospinal Fluid Biomarkers in Patients with Rapidly Progressive Dementia. Annals of Neurology. 95(2). 299–313. 8 indexed citations

Henson, Rachel L., Benjamin Saef, Courtney L. Sutphen, et al.. (2022). A methodology for normalizing fluid biomarker concentrations across reagent lots. Alzheimer s & Dementia. 18(S5).

Butt, Omar H., Justin M. Long, Rachel L. Henson, et al.. (2021). Cognitively normal APOE ε4 carriers have specific elevation of CSF SNAP-25. Neurobiology of Aging. 102. 64–72. 10 indexed citations

Day, Gregory S., Péter Körtvelyessy, Harald Prüß, et al.. (2021). Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis. Neurology. 96(20). e2546–e2557. 45 indexed citations

Sutphen, Courtney L., Lena McCue, Elizabeth Herries, et al.. (2018). Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease. Alzheimer s & Dementia. 14(7). 869–879. 108 indexed citations

Willemse, Eline A.J., Ann De Vos, Elizabeth Herries, et al.. (2018). Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study. Clinical Chemistry. 64(6). 927–937. 32 indexed citations

10.

Willemse, Eline A.J., Ann De Vos, Elizabeth Herries, et al.. (2017). [O1–05–04]: CLINICAL PERFORMANCE OF NEUROGRANIN AS A CEREBROSPINAL FLUID BIOMARKER FOR ALZHEIMER's DISEASE: AN ASSAY COMPARISON STUDY. Alzheimer s & Dementia. 13(7S_Part_4). 4 indexed citations

11.

Sutphen, Courtney L., Elizabeth Herries, Dan L. Crimmins, et al.. (2016). P1‐006: Emerging CSF Biomarkers of Neuroinflammation, Neuronal Injury And Synaptic Integrity in the Adni Cohort. Alzheimer s & Dementia. 12(7S_Part_8). 1 indexed citations

12.

Tarawneh, Rawan, Gina D’Angelo, Dan L. Crimmins, et al.. (2016). Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease. JAMA Neurology. 73(5). 561–561. 163 indexed citations

13.

Ju, Yo‐El S., Mary Beth Finn, Courtney L. Sutphen, et al.. (2016). Obstructive sleep apnea decreases central nervous system–derived proteins in the cerebrospinal fluid. Annals of Neurology. 80(1). 154–159. 110 indexed citations

14.

Kester, Maartje I., Charlotte E. Teunissen, Courtney L. Sutphen, et al.. (2015). Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer’s disease in a memory clinic cohort. Alzheimer s Research & Therapy. 7(1). 59–59. 105 indexed citations

15.

Kester, Maartje I., Charlotte E. Teunissen, Daniel L. Crimmins, et al.. (2015). Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease. JAMA Neurology. 72(11). 1275–1275. 186 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact